The accelerating sales growth of Johnson & Johnson's Spravato could go up yet another gear after the FDA approved a third ...
The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...
Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease.